Form D/A — InSitu Biologics, Inc.
0001723443-26-000008 · filed Nov 10, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $19,837,423
- Reported amount sold
- $15,037,850
- Minimum investment
- $1,850
- Investors
- 27
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- InSitu Biologics, Inc.
- CIK
- 1723443
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3510 HOPKINS PLACE N.
OAKDALE, MN 55128 - Phone
- 651-337-4799
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Halpern · Executive OfficerOakdale, MN Find on LinkedIn ↗
-
William Taylor · Executive OfficerOakdale, MN Find on LinkedIn ↗
-
Sandi Klemann · Executive OfficerOakdale, MN Find on LinkedIn ↗
-
Robert Wilson · DirectorOakdale, MN Find on LinkedIn ↗
-
Greg Van Guilder · DirectorOakdale, MN Find on LinkedIn ↗
-
Ivan Shaw · DirectorOakdale, MN Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗